Skip to main content
Garrett Lam, MD, Obstetrics & Gynecology, Provo, UT

GarrettK.LamMDFACOG

Obstetrics & Gynecology • Provo, UT

Maternal & Fetal Medicine/High Risk

Consultant and Physician

Join to view full profile

Dr. Lam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lam's full profile

Already have an account?

Summary

  • Director of MFM services in the southern market for the Canyons region of intermountain Health. Professor Ob/Gyn University of Kentucky MFM and associate at High Risk Pregnancy Center, Reno, NV. Chief Medical Officer at Ultrasound.AI, a startup harnessing the power of artificial intelligence that recognizes inherent signals in obstetrical sonograms to predict obstetrical complications. Previously served as Chief Medical Officer at Sera Prognostics, which developed the PreTRM blood test to objectively assesses a mother's individual risk of premature birth.
    My work experiences have encompassed full time clinical office and hospital based consultation, obstetrical procedures including percutaneous and open fetal surgery, administrative leadership, QA/QC responsibilities for level III perinatal centers, completion of national and international clinical research projects, collaboration with industry based R&D and commercial teams, and service on national committees regarding clinical guideline communication and implementation of utilization strategies useful to the practicing community. I remain involved with research, primarily focusing on methods and solutions for detection and treatment of preeclampsia and preterm labor. I also work with fellows and junior faculty regarding professional development activities.

    • Testing for Premature Birth Risk: Sera Prognostics

    Sera Prognostics is the developer of the PreTRM test, an innovative blood test that predicts an expectant mother's risk of premature birth.

    Sera Prognostics Receives New York State Approval for PreTRM® Testing

    Dec. 12, 2018 -- Sera Prognostics, The Pregnancy Company(™), announced that the New York State Department of Health has issued a clinical laboratory permit for

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Maternal-Fetal Medicine, 2000 - 2003
  • University of Arizona College of Medicine-Phoenix
    University of Arizona College of Medicine-PhoenixResidency, Obstetrics and Gynecology, 1996 - 2000
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1996

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2021 - 2025
  • NV State Medical License
    NV State Medical License 2020 - 2025
  • UT State Medical License
    UT State Medical License 2021 - 2024
  • ID State Medical License
    ID State Medical License 2019 - 2024
  • SD State Medical License
    SD State Medical License Active through 2023
  • NC State Medical License
    NC State Medical License 2020 - 2023
  • GA State Medical License
    GA State Medical License 2012 - 2023
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
  • Join now to see all

Awards, Honors, & Recognition

  • Best Doctors in America Best Doctors
  • Top Doctor Castle and Connelly

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm P...  
    Michael J Paidas, George A Macones, Garrett K Lam, Everett F Magann, Erika F Werner, Mounira A Habli, Chad A Grotegut, Sherri A Longo, Erol Amon, William A Grobman, De..., American Journal of Obstetrics and Gynecology

Authored Content

  • Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)August 2020

Press Mentions

  • Slone Partners, Where People Are Our Science™, Places New Chief Medical Officer, Garrett K. Lam M.D. FACOG, at Sera Prognostics, Inc
    Slone Partners, Where People Are Our Science™, Places New Chief Medical Officer, Garrett K. Lam M.D. FACOG, at Sera Prognostics, IncJuly 17th, 2018

Professional Memberships

Other Languages

  • Spanish

Dr. Garrett Lam, Dr. Garrett Lam, MD, Dr. G Lam, Dr. Garrett K. Lam